PlexusDx vs Brello Health — 2026 Pricing, Plans, and Verdict

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health's three-month prepaid plans cost $399 for compounded semaglutide injection (four cycles annually = $1,596/year) and $499 for compounded tirzepatide injection (4.7 cycles annually = $2,359/year). PlexusDx three-month commitments run $169/month for semaglutide ($2,028/year) and $269/month for tirzepatide ($3,228/year), billed monthly. Over 12 months, Brello's semaglutide plan costs $432 less and its tirzepatide plan costs $869 less than PlexusDx equivalents. The core trade-off: prepaying $399 or $499 every cycle for Brello's lower annual cost versus monthly billing and a shallower upfront commitment with PlexusDx. Neither option charges membership fees; both use compounded medication from 503A pharmacies.

At-a-glance comparison: three-month plans

Sources: Brello Health pricing captured from brellohealth.com/home1 and tirzepatidewoo.brellohealth.com on 2026-09-04; PlexusDx pricing from internal product data captured 2026-07-17 to 2026-07-23.

Normalized 12-month costs: prepaid cycles versus monthly billing

To compare like-for-like three-month commitment plans, we calculate the annual cost of each option assuming continuous use over 12 months.

Semaglutide injection: 12-month comparison

Brello Health (three-month prepaid):

• $399 per three-month cycle
• 4 cycles per year = $399 × 4 = $1,596 annually (our calculation)
• Prepaid monthly average: $1,596 ÷ 12 = $133/month (our calculation)

PlexusDx (three-month commitment, monthly billing):

• $169/month × 12 months = $2,028 annually (our calculation)

Annual difference: Brello's semaglutide plan costs $432 less per year than PlexusDx's three-month commitment plan (our calculation).

Tirzepatide injection: 12-month comparison

Brello Health (three-month / 11-week prepaid):

• $499 per 11-week cycle
• 52 weeks ÷ 11 weeks = 4.727 cycles per year
• $499 × 4.727 = $2,359 annually (our calculation)
• Monthly average: $2,359 ÷ 12 = $197/month (our calculation)

PlexusDx (three-month commitment, monthly billing):

• $269/month × 12 months = $3,228 annually (our calculation)

Annual difference: Brello's tirzepatide plan costs $869 less per year than PlexusDx's three-month commitment plan (our calculation).

All annual figures and monthly averages are our calculation based on advertised per-cycle pricing. Confirm renewal terms and prepayment requirements at checkout.

What drives the cost difference?

Brello Health's lower annual cost comes from prepaid multi-month cycles. You pay $399 or $499 upfront, then renew at the same cycle price; PlexusDx's three-month commitment spreads the same commitment duration across monthly bills. Brello's tirzepatide cycle is explicitly stated to rebill every 11 weeks with anytime cancellation; semaglutide is advertised as a three-month supply with a three-month minimum, but renewal terms should be confirmed at checkout.

Both programs charge the same price at every dose: neither penalizes titration with higher prices as you progress through maintenance. Neither charges membership fees, hidden lab costs, or shipping fees; medication, provider access, and delivery are included in the published rates.

PlexusDx also offers month-to-month plans ($189/month for semaglutide, $289/month for tirzepatide) if you want no commitment and minimal upfront cost, though the per-month rate is higher than the three-month tier.

Billing structure and cash-flow implications

Brello Health: Prepaid cycles require $399 (semaglutide) or $499 (tirzepatide) at the start of each cycle. If you pay for three months of semaglutide, you commit $399 upfront. Tirzepatide cycles run 11 weeks, so you'll prepay roughly 4.7 times per year. The lower annual cost is the payoff for larger, less frequent charges.

PlexusDx: Monthly billing spreads the three-month commitment into smaller installments: $169 or $269 each month. Your first-month charge is $169 or $269, not $507 or $807, which may be easier to budget. The three-month commitment means you agree to three billing cycles, but you're not prepaying all three upfront.

If cash flow is tight or you want to test tolerance before committing $399–$499, PlexusDx's monthly billing may fit better. If you can prepay and want the lowest annual cost, Brello's structure delivers that.

Medication and regulatory status

Both Brello Health and PlexusDx prescribe compounded semaglutide and tirzepatide prepared by 503A compounding pharmacies. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Neither program offers branded Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded formulations are not interchangeable with branded products and may vary in concentration, delivery mechanism, or excipients.

Cancellation and flexibility

Brello Health's tirzepatide page states "cancel anytime." The semaglutide page notes a "three-month minimum," but evidence does not specify whether this is a one-time minimum or a recurring obligation. Confirm cancellation and renewal terms at checkout before committing.

PlexusDx three-month commitment plans can be canceled anytime, though you remain responsible for the current billing cycle. Month-to-month plans carry no commitment beyond the current month.

Choose Brello Health if…

• You can comfortably prepay $399 (semaglutide) or $499 (tirzepatide) every cycle and want the lowest annual cost.
• You prefer infrequent billing events (every three months or 11 weeks) over monthly charges.
• Annual savings of $432 (semaglutide) or $869 (tirzepatide) justify the larger upfront payment.
• You've already confirmed tolerance and expect to continue treatment for at least a year.

Choose PlexusDx if…

• Monthly billing fits your budget better than $399–$499 upfront commitments.
• You want shallow first-month exposure ($169 or $269) while assessing tolerance and response.
• You value flexibility to step down to month-to-month plans ($189 semaglutide, $289 tirzepatide) or explore other options (oral semaglutide capsules at $269/month on a three-month plan, microdose GLP-1 maintenance at $129/month) within one platform.
• You prefer not to prepay multiple months of medication before you know how your body responds.

Other PlexusDx options worth considering

If Brello's prepaid structure feels too rigid but PlexusDx's three-month semaglutide plan ($169/month) still seems high, consider:

• Six-month semaglutide commitment: $149/month ($1,788/year), billed monthly. Annual cost is $192 more than Brello's prepaid plan but requires no upfront lump sum.
• Month-to-month semaglutide: $189/month ($2,268/year) with zero commitment. Highest per-month rate but total flexibility.
• Microdose GLP-1 maintenance: $129/month once you've reached goal weight and want to sustain results at a lower dose. No commitment tier required.

For tirzepatide, PlexusDx's six-month plan drops to $249/month ($2,988/year), which is $629 more annually than Brello's prepaid option but avoids the $499 recurring upfront charge.

Methodology and freshness

We captured Brello Health's advertised pricing from brellohealth.com/home1 and tirzepatidewoo.brellohealth.com on 2026-09-04. PlexusDx pricing reflects internal product data verified between 2026-07-17 and 2026-07-23. All annual cost figures and monthly averages are our calculation, derived by multiplying per-cycle or per-month rates across 12 months. We calculated Brello's tirzepatide annual cost by dividing 52 weeks by the advertised 11-week cycle length (4.727 cycles) and multiplying by $499. Prepaid monthly averages (e.g., "$133/month" for Brello semaglutide) are our calculation and represent the annual cost divided by 12; the actual billing event is the lump-sum cycle charge. Confirm all pricing, renewal terms, and cancellation policies at checkout; advertised rates can change, and promotional offers may apply.

Frequently Asked Questions

Does Brello Health charge any membership or subscription fees beyond the medication cost?

No. Brello Health's advertised pricing is all-inclusive: medication, provider access, and shipping are bundled into the $399 (semaglutide) or $499 (tirzepatide) cycle charge, with no separate membership fee. Confirm this at checkout in case program terms have changed.

Can I switch from a PlexusDx three-month plan to month-to-month later?

Yes. PlexusDx three-month commitments can be canceled anytime, and you can restart on a month-to-month plan if you prefer flexibility. You remain responsible for the current billing cycle. Contact support to confirm transition timing and ensure no gap in medication.

What happens if I need to stop treatment mid-cycle on Brello's prepaid plan?

Brello's tirzepatide page states "cancel anytime," but it is unclear whether prepaid cycle fees are prorated or refunded if you stop early. Semaglutide terms are less explicit. Confirm the refund and cancellation policy at checkout before committing $399 or $499 upfront.

Are compounded semaglutide and tirzepatide as effective as Ozempic, Wegovy, Mounjaro, or Zepbound?

Compounded medications are not FDA-approved and are not clinically interchangeable with branded products. Efficacy, purity, and consistency are not independently verified by FDA. A licensed clinician determines whether compounded GLP-1 therapy is appropriate for you, but no provider can guarantee results or interchangeability with branded drugs.

Which plan should I choose if I'm unsure how long I'll need GLP-1 therapy?

Start with PlexusDx's month-to-month option ($189 semaglutide, $289 tirzepatide) or a three-month commitment plan to test tolerance and response. Brello's prepaid cycles deliver the lowest annual cost, but they require confidence that you'll continue for multiple cycles. Avoid large upfront commitments until you know how your body responds.

Sources

• PlexusDx internal product pricing data, verified 2026-07-17 to 2026-07-23.
• Brello Health semaglutide and tirzepatide pricing, captured from https://www.brellohealth.com/home1 on 2026-09-04.
• Brello Health tirzepatide detail page, captured from https://tirzepatidewoo.brellohealth.com/ on 2026-09-04.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.